Newsroom

group picture
News
The German Research Foundation (DFG) is funding the DEEP-DV research group for another four years with a total of €5.3 million. This marks the second phase of the successful work of the interdisciplinary group, which includes scientists from Braunschweig, Hamburg, Hannover, Berlin, Regensburg, Ulm, Freiburg, and Munich. DNA viruses such as herpes viruses and polyomaviruses can remain in the body permanently after an initial infection and cause serious health consequences years later.
10.07.2025
Impfstoff
News
A recent study led by the Centre for Individualised Infection Medicine (CiiM) and the Radboud University Medical Center published in Genome Biology shows that BCG vaccination does more than fend off tuberculosis - it leaves enduring chemical marks on immune cells that boost responses to various pathogens. Researchers also uncover hormone‑immune crosstalk and sex‑specific effects that could guide next‑generation, individualised vaccine design.
10.07.2025
Dr. Andreas Pavlou, first author of the study, in the lab
News
Infections in the brain can have serious consequences and are often fatal. The immune defense system works differently here than in the rest of the body. A team of researchers at TWINCORE – Centre for Experimental and Clinical Infection Research in Hanover – has now discovered, in collaboration with partners, which signaling pathways play a central role in communication between immune cells in the brain in their defense against viruses. The results have now been published in the Journal of Neuroinflammation. The TWINCORE is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Hannover Medical School (MHH).
09.07.2025
[Translate to English:] Empfangsschild des Arabuko-Sokoke-Nationalparks
Story
Natural substances are an important source of active ingredients used in medicine. However, the chemical diversity of fungi in particular has not yet been sufficiently researched. The EU project Mycobiomics, coordinated by Marc Stadler, Head of the Department “Microbial Drugs” at the Helmholtz Centre for Infection Research (HZI), is investigating the biodiversity of fungi in Europe, Asia and Africa in order to identify pharmaceutically valuable secondary metabolites. In May and June 2025, project participants met in Kenya and South Africa for an expedition and a subsequent symposium.
09.07.2025
The One Health Surveillance team from HIOH receives the award for “Best Research Environment 2024”.
News
Excellent conditions for research, an inspiring atmosphere and fair cooperation: for all this, the research group “One Health Surveillance” (OHS) at the Helmholtz Institute for One Health (HIOH) has been awarded the “Best Research Environment 2024” prize by the Junge Akademie. Under the leadership of Dr. Fee Zimmermann, the OHS group is establishing health and environmental observatories, so-called “One Health Exploratories”, which collect long-term and systematic data on the health of humans, animals and the environment and integrate it into a big picture. The HIOH is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig in cooperation with the University of Greifswald, the University Medicine Greifswald and the Friedrich-Loeffler-Institut.
09.07.2025
Electron micrograph of coccal bacteria growing in chains
News
Influenza viruses can trigger epigenetic changes in the alveolar epithelium, the cell layer that lines the alveoli, permanent changes in gene activity without changing the DNA itself. These changes have a lasting effect on subsequent immune responses and result in the body no longer being able to react appropriately to the bacterial pathogens in the event of a subsequent infection with pneumococci. A research team at the Helmholtz Centre for Infection Research (HZI) and the University Hospital Magdeburg (UMMD) has published new findings on the long-term consequences of an influenza A infection in a mouse model in the journal Cell Communication and Signaling.
04.07.2025

HZI in the media

Fermentation und Aufreinigung, wurde ebenfalls am HZI in der Arbeitsgruppe von Prof. Marc Stadler, stellvertretender ...

06.02.2026
|
juraforum.de

... gehört habt: Phagen. Spoiler: Was am Helmholtz-Zentrum für Infektionsforschung (HZI) passiert, rettet im Zweifel Leben – ...

05.02.2026
|
Redaktionsnetzwerk Deutschland

Mattioli an: Am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

04.02.2026
|
Universitätsklinikum Würzburg

MWK) und der VolkswagenStiftung hat das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig das Großprojekt HUMAN ...

03.02.2026
|
Regional Heute

Im Programm HUMAN am Helmholtz-Zentrum für Infektionsforschung in Braunschweig entschlüsselt die nächste Generation Forschender das ...

03.02.2026
|
VolkswagenStiftung

Quelle: Pressemitteilung

 

Helmholtz-Zentrum für Infektionsforschung GmbH

03.02.2026
|
LaborPraxis

der Medizinischen Hochschule Hannover und des Helmholtz-Zentrums für Infektionsforschung wollen seltene rheumatische Erkrankungen des

02.02.2026
|
Niedersächsisches Landesjustizportal

MWK) und der VolkswagenStiftung hat das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig das Großprojekt HUMAN ...

02.02.2026
|
juraforum.de

... an anderen Forschungseinrichtungen gearbeitet, beispielsweise am Helmholtz-Institut für Pharmazeutische Forschung Saarland. Was sind die ...

02.02.2026
|
Deutschlandfunk

waren mehrere Forschungseinrichtungen beteiligt, darunter das Helmholtz-Zentrum für Infektionsforschung . Die Ergebnisse erschienen im

02.02.2026
|
Münchner Merkur

Medicine (CiiM), which is a joint institution of the Helmholtz Center for Infection Research (HZI) and Hannover Medical School (MHH). Using

29.01.2026
|
Medical Xpress

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

27.01.2026
|
Tvinfo.de

Register now for the HZI-Newsletter